Cargando…
Barriers and Strategies: A Review of Access to Affordable Multi-Drug Resistant Tuberculosis Medication in China
This study analyzed the barriers of patient access to affordable MDR-TB medication in China and the reasons behind, and proposed strategies towards removing the barriers based on literature review and key informant interviews. Reasons behind the high financial burden of MDR-TB patients in China are...
Autores principales: | Zhang, Yuou, Liu, Xuan, Yang, Linghe, Zhang, Guifang, Gu, Zhaoru, Chen, Zhongdan, Sun, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585516/ https://www.ncbi.nlm.nih.gov/pubmed/33116687 http://dx.doi.org/10.2147/IDR.S256128 |
Ejemplares similares
-
Unblocking Barriers of Access to Hepatitis C Treatment in China: Lessons Learned from Tianjin
por: Zhang, Peiwen, et al.
Publicado: (2020) -
Ensuring Access to Affordable Drug Coverage in Medicare
por: Antos, Joseph R.
Publicado: (2005) -
Impact of universal medical insurance system on the accessibility of medical service supply and affordability of patients in China
por: Xiong, Xiaolei, et al.
Publicado: (2018) -
Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China
por: Hutchison, C., et al.
Publicado: (2017) -
Access to and affordability of healthcare for TB patients in China: issues and challenges
por: Tang, Shenglan, et al.
Publicado: (2016)